WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...
A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.
Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the agreement, NAMSA will take ownership of WuXi’s facilities in Minnesota and Georgia.
Fan Weiqu, 62, killed 35 in a car rampage in Zhuhai, while Xu Jiajin, 21, fatally stabbed eight at a vocational school in Wuxi. Both acts, rooted in personal grievances, highlight a rise in “revenge ...
BEIJING (AP) -- China has executed two men who committed deadly attacks that killed dozens in November and raised concerns about a surge in what are called "revenge on society crimes," state media ...
Also in November, 21-year-old Xu Jiajin killed eight people and injured 17 others in a stabbing attack at his vocational school in the eastern city of Wuxi. Police said Wu had failed his ...
Xu Jiajin, who killed eight and injured 17 on a campus in Wuxi, Jiangsu province, in November, was executed on Monday after China's top court had approved his death sentence. The execution was ...
BGI, Complete Genomics, MGI, WuXi AppTec, and WuXi Biologics are obvious targets for The BIOSECURE Act. It is well known that WuXi entities have become dangerously entwined with American biotech.
1 Day 603259 -0.99% DJIA 0.79% S&P 500 0.91% Health Care/Life Sciences 66.70% ...
Plus, news about Neurizon: WuXi AppTec divests again: The company is selling its US medical device testing operations, including facilities in Minnesota and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results